Inhibitory effect of Panax notoginseng on nitric oxide synthase, cyclo-oxygenase-2 and neutrophil functions

Phytotherapy Research

Volumn 21, Issue 2, 2007, Pages 142-148

  Jin, Un Ho ^a   Park, Soon Gi ^b   Suh, Seok Jong ^a   Kim, June Ki ^b   Kim, Dong Soo ^c   Moon, Sung Kwon ^d   Lee, Young Choon ^e   Park, Won Hwan ^b   Kim, Cheorl Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b Dongguk University   (South Korea)

^c Kyungsung University   (South Korea)

^d Chungju National University   (South Korea)

^e Dong A University   (South Korea)

Author keywords

Carrageenan paw oedema; Macrophage; Neutrophil; Nitric oxide; Panax notoginseng Buck F.H. Chen. (Arialiaceae)

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CARRAGEENAN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ELASTASE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PANAX NOTOGINSENG EXTRACT; PROSTAGLANDIN E2; SUPEROXIDE;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DEGRANULATION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; NEUTROPHIL; PAW EDEMA; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 5-LIPOXYGENASE; CELL DEGRANULATION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DRUGS, CHINESE HERBAL; HUMANS; INDOMETHACIN; LEUKOTRIENE B4; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICROSOMES; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PANAX NOTOGINSENG; PANCREATIC ELASTASE; SUPEROXIDES; THROMBOXANE B2;

PANAX NOTOGINSENG;

EID: 33846990944     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2018     Document Type: Article

References (36)

1. Ahn JC. 2003. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis in LEC rats and gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats. J Kor Oriental Med Diagnos 22: 203-208.
2. Brownlie RP, Brownrigg NJ, Butcher HM et al. 1993. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro. Br J Pharmacol 110: 1600-1606.
3. Bustos G, Ferrandiz ML, Sanz MJ, Paya M, Alcaraz MJ. 1995. A study of the novel anti-inflammatory agent florifenine. Topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions. Naunyn Schmiedebergs Arch Pharmacol 351: 298-304.
4. Cicero AFG, Bandieri E, Arletti R. 2000. Orally administered Panax notoginseng influence on rat spontaneous behavior. J Ethnopharmacol 73: 387-391.
5. Escrig V, Ubeda A, Ferrandiz ML et al. 1997. A dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity. J Pharmacol Exp Ther 282: 123-131.
6. Fujiwara K, Ohta Y, Ogata I. 1987. Treatment trial of traditional oriental medicine in chronic viral hepatitis. In New Trends in Peptic Ulcer and Chronic Hepatitis: Part II Chronic Hepatitis, Ohta Y (ed.). Excerpta Medica: Tokyo, 141-146.
7. Gross SS, Levi R. 1992. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722-25729.
8. 2+, CaM in craniocerebral injury. Chin J Integrated Trad Western Med 194: 227-229.
9. Hasegawa H, Lee KS, Nagaoka T et al. 2000. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol Pharm Bull 233: 298-304.
10. Henderson WR. 1994. The role of leukotrienes in inflammation. Ann Intern Med 121: 684-697.
11. Ianaro A, O'Donnell CA, Di Rosa M, Liew FY. 1994. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82: 370-375.
12. Kang RY, Freire Moar J, Sigal E, Chu CQ. 1996. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol 35: 711-718.
13. Li XC. 1998. Chinese herbal study on anti-ischemia-reperfusion-injury. Chin J Hosp Pharm 154: 1-4.
14. Li XH, Li SH. 1999. Effects of total saponins of Sanchi (Panax pseudo-ginseng notoginseng) on TNF, NO and its mechanisms. Chin Trad Herbal Drugs 307: 514-517.
15. 2+ concentration in dissociated neurons. Chin. Pharm. J 338: 467-469.
16. Ma LY, Xiao PG, Liang FQ, Wu JH. 1998. Protective effects of Panax notoginseng saponins on primary cortical cultures of rat. Chin Pharmaceut J 333: 143-144.
17. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350.
18. Marcinkiewicz J, Grabowska A, Chain B. 1995. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25: 947-951.
19. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. 1993. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214: 11-16.
20. Mitchell JA, Sheng H, Forstermann U, Murad F. 1991. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle. Br J Pharmacol 104: 289-291.
21. Moroney MA, Alcaraz MJ, Forder RA, Carey F, Hoult JRS. 1988. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 40: 787-792.
22. Ohtani K, Mizutani K, Hatono S et al. 1987. Sanchinan-A, a reticuloendothelial system activating arabinogalactan from sanchi-ginseng (roots of Panax notoginseng). Planta Med. 53: 166-169.
23. Park C, Shim JK, Kim JR et al. 1999. Inhibitory effects of streptozotocin, TNF-α and IL-1β on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase. Arch Biochem Biophys 362: 217-224.
24. Salter M, Knowles RG, Moncada S. 1991. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett 291: 145-149.
25. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PT. 1996. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol 303: 217-220.
26. Sanada S, Shoji J, Shibata S. 1978. Quantitative analysis of ginseng saponins. Yakugaku Zasshi 98: 1048-1054.
27. Seibert K, Zhang Y, Leahy K et al. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91: 12013-12017.
28. Shen YJ. 2000. Pharmacology of Traditional Chinese Medicine. Renmin Weisheng Press: Beijing, China.
29. Smith JA. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukocyte Biol 56: 672-686.
30. Sugishita E, Amagaya S, Ogihara Y. 1981. Anti-inflammatory testing methods: comparative evaluation of mice and rats. J Pharmacobiodyn 4: 565-575.
31. Suh SJ, Chung TW, Son MJ et al. 2006. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch Biochem Biophys 447: 136-146.
32. Tateson JE, Randall RW, Reynolds CH et al. 1988. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol 94: 528-539.
33. Yamaguchi H, Kasai R, Matsuura H, Tanaka O, Fuwa T. 1988. High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 36: 3468-3473.
34. Yoshikawa M, Morikawa T, Yashiro K, Murakami T, Matsuda H. 2001. Bioactive saponins and glycosides. XIX. Notoginseng (3): immunological adjuvant activity of notoginsenosides and related saponins: structures of notoginsenosides-L, -M, and -N from the roots of Panax notoginseng (Burk.) F. H. Chen. Chem Pharm Bull 49: 1452-1456.
35. Zhang GQ, Ye RG, Kong QY et al. 1998. Panax notoginseng saponins induced of human renal interstitial fibroblasts and its mechanisms. Chin J Nephrol 142: 93-95.
36. Zhu XX, Mao YW, He RX, Yamamoto A, Shoyama Y. 1998. Determination of ginsenosides in Panax ginseng by HPLC. Chin J Biochem Pharm 191: 28-30.